$2.61 -0.09 (-3.33%) Rigel Pharmaceuticals Inc - NASDAQ

Aug. 26, 2016 | 04:00 PM
Last Trade: 2.61
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: -0.09 (-3.33%)
Prev Close: 2.70
Open: 2.72
Bid: 2.61
Ask: 2.62
  1. No results found.
  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  7. Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down

    Benzinga | Feb. 23, 2015 | 08:57AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 23, 2015 | 08:09AM EST
  9. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  10. What You Need to Know About the Roche-InterMune Deal

    Benzinga | Aug. 29, 2014 | 15:51PM EST
  11. InterMune's Roche Deal Sends Peer Group Up

    Benzinga | Aug. 25, 2014 | 11:38AM EST
  12. Morning Market Losers

    Benzinga | Aug. 13, 2014 | 09:51AM EST
  13. Rigel Initiates Phase 3 Studies Of Fostamatinib In ITP

    Benzinga | Jul. 16, 2014 | 08:38AM EST
  14. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 6, 2014 | 08:11AM EST
  15. Earnings Scheduled For March 4, 2014

    Benzinga | Mar. 4, 2014 | 04:35AM EST
Trading Center